Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05895201
What this trial is testing

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

Who this might be right for
Bone Marrow Transplant ComplicationsAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia, Adult+2 more
Indiana University
Not applicableWithdrawnNCT02842372
What this trial is testing

Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease in Skin
Bitop AG
Not applicableStudy completedNCT01521039
What this trial is testing

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft-versus-Host DiseaseAllogeneic Stem Cell Transplant
Ohio State University Comprehensive Cancer Center 259
Testing effectiveness (Phase 2)UnknownNCT01754454
What this trial is testing

Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease

Who this might be right for
Acute GVH Disease
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03842696
What this trial is testing

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
Hematologic DiseasesAcute Leukemia in RemissionChronic Myelogenous Leukemia - Chronic Phase+9 more
University of Michigan Rogel Cancer Center 43
Very early researchStudy completedNCT02117115
What this trial is testing

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic+1 more
Washington University School of Medicine 21
Post-approval studies (Phase 4)UnknownNCT04636918
What this trial is testing

Ikervis for DED Due to GVHD Post Allo-HSCT

Who this might be right for
Leukemia (Both ALL and AML)MDS-EB-1
Singapore Eye Research Institute 40
Testing effectiveness (Phase 2)UnknownNCT05808985
What this trial is testing

Intestinal Microbiome-based Research for the Prevention of Acute GVHD

Who this might be right for
Graft Versus Host DiseasePostbioticsButyrate
Soonchunhyang University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02206035
What this trial is testing

Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
William R. Drobyski, MD 45
Testing effectiveness (Phase 2)Looking for participantsNCT07570745
What this trial is testing

Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors

Who this might be right for
Graft-Versus-Host Disease(GVHD)Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 82
Not applicableUnknownNCT06335277
What this trial is testing

Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

Who this might be right for
LeukemiaLeukemia, ChronicLeukemia, Acute+2 more
European Institute of Oncology 50
Testing effectiveness (Phase 2)UnknownNCT04971551
What this trial is testing

Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Who this might be right for
Acute Graft-Versus-Host Disease
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Not applicableStudy completedNCT00340951
What this trial is testing

Can Immune Parameters Predict Acute and Chronic Rejection in Lung Recipients?

Who this might be right for
Lung Transplantation
National Institute of Environmental Health Sciences (NIEHS) 400
Testing effectiveness (Phase 2)Study completedNCT03613727
What this trial is testing

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Lymphoid LeukemiaMyeloid LeukemiaMonocytic Leukemia+1 more
Virginia Commonwealth University 61
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Testing effectiveness (Phase 2)Ended earlyNCT05415410
What this trial is testing

Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)

Who this might be right for
GVHD
VectivBio AG 31
Testing effectiveness (Phase 2)Study completedNCT01700036
What this trial is testing

A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease

Who this might be right for
Graft vs Host Disease
University of Michigan Rogel Cancer Center 40
Not applicableStudy completedNCT00339209
What this trial is testing

Prospective Lung Transplant Database for Genetic Research

Who this might be right for
Lung Transplantation Rejection
National Institute of Environmental Health Sciences (NIEHS) 400
Early research (Phase 1)UnknownNCT05823675
What this trial is testing

Safety and Clinical Activity of Itolizumab in aGVHD

Who this might be right for
Acute Graft Versus Host Disease
Biotech Pharmaceutical Co., Ltd. 44
Next Page